Cipla Europe NV, a wholly-owned subsidiary of Cipla Ltd on 20 November 2014 tied up with Serum Institute of India Ltd (SII) to distribute vaccines in Europe.
Under the agreement, SII will develop and manufacture paediatric vaccines. On the other hand, Cipla will seek European Medicines Agency approval and market the products in Europe.
Serum Institute of India Ltd (SII)
Serum Institute of India was founded in 1966 with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices.
Today, Serum Institute of India Ltd is the World's largest producer of Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines.
Vaccines manufactured by the Serum Institute are accredited by the World Health Organization and are being used in around 140 countries across the globe in their national immunization programs.
Comments
All Comments (0)
Join the conversation